Literature DB >> 15285844

Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells.

Shuji Kitagawa1, Tomohiro Nabekura, Shizu Kamiyama.   

Abstract

We studied the effects of tea catechins, (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin gallate (ECG), and (-)-epigallocatechin gallate (EGCG) on the P-glycoprotein (P-gp) function in multidrug-resistant P-gp over-expressing KB-C2 cells. EC did not have any effects on cellular accumulation of P-gp substrates, rhodamine-123 and daunorubicin, but the other catechins increased the accumulation in the order of EGC < ECG < EGCG. The effects of EGCG were larger than those of verapamil and quercetin. Since these catechins inhibited the efflux of P-gp substrates, the elevation of substrate accumulation seemed to be induced by the inhibition of the efflux transporter. The results showed that the inhibitory effects of the catechins did not depend on their total hydrophobicity, but significantly depended on their chemical structure. The presence of the galloyl moiety on the C-ring markedly increased the n-octanol/PBS partition coefficients of the catechins and their activity on P-gp. On the other hand, the presence of the trihydric pyrogallol group as the B-ring decreased the partition coefficients but increased the activity on P-gp, compared with the action of the corresponding catechins with a dihydric catechol B-ring.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15285844     DOI: 10.1211/0022357044003

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  23 in total

Review 1.  Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.

Authors:  Min Shen; Tak Hang Chan; Q Ping Dou
Journal:  Anticancer Agents Med Chem       Date:  2012-10-01       Impact factor: 2.505

Review 2.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors:  Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

Review 3.  Antioxidants from black and green tea: from dietary modulation of oxidative stress to pharmacological mechanisms.

Authors:  Ilaria Peluso; Mauro Serafini
Journal:  Br J Pharmacol       Date:  2016-11-12       Impact factor: 8.739

4.  Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.

Authors:  Shingen Misaka; Osamu Abe; Hideyuki Sato; Tomoyuki Ono; Yayoi Shikama; Satomi Onoue; Hirooki Yabe; Junko Kimura
Journal:  Eur J Clin Pharmacol       Date:  2018-01-24       Impact factor: 2.953

5.  Effects of antioxidants on drug absorption in in vivo intestinal ischemia/reperfusion.

Authors:  Yusuke Takizawa; Takuya Kitazato; Hisanao Kishimoto; Mikio Tomita; Masahiro Hayashi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-12-24       Impact factor: 2.441

Review 6.  Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.

Authors:  Chung-Pu Wu; Shinobu Ohnuma; Suresh V Ambudkar
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

7.  Curcumin Rescues Doxorubicin Responsiveness via Regulating Aurora a Signaling Network in Breast Cancer Cells.

Authors:  Souvick Biswas; Elizabeth Mahapatra; Archismaan Ghosh; Salini Das; Madhumita Roy; Sutapa Mukherjee
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

8.  Chemotherapy and dietary phytochemical agents.

Authors:  Katrin Sak
Journal:  Chemother Res Pract       Date:  2012-12-20

9.  Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals.

Authors:  Abdel-Moneim M Osman; Sameer E Al-Harthi; Ohoud M AlArabi; Mohamed F Elshal; Wafaa S Ramadan; Mohamed N Alaama; Huda M Al-Kreathy; Zoheir A Damanhouri; Osman H Osman
Journal:  Cancer Cell Int       Date:  2013-05-28       Impact factor: 5.722

10.  Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line.

Authors:  Abdel-Moneim M Osman; Hadeel M Bayoumi; Sameer E Al-Harthi; Zoheir A Damanhouri; Mohamed F Elshal
Journal:  Cancer Cell Int       Date:  2012-11-16       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.